Ngā hua rapu - Jacek Jassem

Whakamahine hua
  1. 1
    Tobacco smoking after diagnosis of cancer: clinical aspects

    Tobacco smoking after diagnosis of cancer: clinical aspects mā Jacek Jassem

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Systemic therapy for cervical carcinoma – current status

    Systemic therapy for cervical carcinoma – current status mā Krystyna Serkies, Jacek Jassem

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review

    Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review mā Bartłomiej Tomasik, Marcin Skrzypski, Michał Bieńkowski, Rafał Dziadziuszko, Jacek Jassem

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review

    Patient Eligibility and Results for Brain Metastasis in Phase 3 Trials of Advanced Breast Cancer: A Scoping Review mā Renata Duchnowska, Everardo D. Saad, Małgorzata Banaszek, Ewa Pawłowska, Hanna Liberek, Natalia Cichowska-Cwalińska, Jacek Jassem

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Deep Learning-Based, Multiclass Approach to Cancer Classification on Liquid Biopsy Data

    Deep Learning-Based, Multiclass Approach to Cancer Classification on Liquid Biopsy Data mā Maksym A. Jopek, Krzysztof Pastuszak, Sebastian Cygert, Myron G. Best, Thomas Würdinger, Jacek Jassem, Anna J. Żaczek, Anna Supernat

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer mā Rafał Dziadziuszko, Anh T. Le, Anna Wrona, Jacek Jassem, D. Ross Camidge, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

    Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma mā Jacek Jassem, Rodryg Ramlau, Armando Santoro, Wolfgang Schuette, Assad Chemaissani, Shengyan Hong, J. Blatter, Susumu Adachi, Axel R. Hanauske, Christian Manegold

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland

    BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland mā Magdalena Ratajska, Izabela Brożek, Elżbieta Senkus, Jacek Jassem, Magdalena Stepnowska, Grazia Palomba, Marina Pisano, Milena Casula, Giuseppe Palmieri, Åke Borg, Janusz Limon

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)

    A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC) mā Elżbieta Senkus, Rafał Dziadziuszko, E. Bednaruk-Młyński, Aleksandra Pliszka, Jadwiga Kubrak, Alicja Lewandowska, Konrad Małachowski, Marek Wierzchowski, M. Matecka-Nowak, Jacek Jassem

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

    Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer mā Rafał Dziadziuszko, Murry W. Wynes, Shalini Singh, Bernadette Reyna Asuncion, James Ranger‐Moore, Krzysztof Konopa, Witold Rzyman, Barbara Szostakiewicz, Jacek Jassem, Fred R. Hirsch

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer

    Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cel... mā Corey J. Langer, Silvia Novello, Keunchil Park, Maciej Krzakowski, Daniel D. Karp, Tony Mok, Rebecca Benner, J. R. Scranton, Anthony J. Olszanski, Jacek Jassem

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    166MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from BEGONIA, a phase Ib/II study

    166MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial... mā Patrick Schmid, K.H. Jung, Piotr J. Wysocki, Jacek Jassem, X. Cynthia, Renan Fernandes, Robert Huisden, Ross Stewart, Petra Vuković, Ana Tablante Nunes, Zbigniew Nowecki

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma mā Michele Maio, Andrzej Maćkiewicz, Alessandro Testori, Uwe Trefzer, Virginia Ferraresi, Jacek Jassem, Claus Garbe, Thierry Lesimple, B. Guillot, Pere Gascón, Katalin Gilde, Roberto Camerini, Francesco Cognetti

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

    First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study mā Olavo Feher, P Vodvářka, Jacek Jassem, G Morack, Suresh H. Advani, K. Khoo, Dinesh Chandra Doval, S. Ermisch, D. Roychowdhury, Michael A. Miller, Gϋnter von Minckwitz

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer

    Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer mā Maciej Bobowicz, Marcin Skrzypski, Piotr Czapiewski, Michał Marczyk, Agnieszka Maciejewska, Michał Jankowski, Anna Szulgo-Paczkowska, Wojciech Zegarski, Ryszard Pawłowski, Joanna Polańska, Wojciech Biernat, Janusz Jaśkiewicz, Jacek Jassem

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Cancer

    Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Canc... mā Filippo de Marinis, José Rodrigues Pereira, Frank V. Fossella, Michael C. Perry, Martin Reck, Marc Salzberg, Jacek Jassem, Patrick Peterson, Astra M. Liepa, Patti Moore, Richard J. Gralla

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer

    Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer mā A. Badzio, Murry W. Wynes, Rafał Dziadziuszko, Daniel T. Merrick, Marta Pardo, Witold Rzyman, Anna Kowalczyk, Shalini Singh, James Ranger‐Moore, Guadalupe Manriquez, Fabien Gaire, Jacek Jassem, Fred R. Hirsch

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab

    Quality of Life in Head and Neck Cancer Patients After Treatment With High-Dose Radiotherapy Alone or in Combination With Cetuximab mā Desmond Curran, J. Giralt, Paul M. Harari, K. Kian Ang, Roger B. Cohen, Merrill S. Kies, Jacek Jassem, José Baselga, Eric K. Rowinsky, Nadia Amellal, Sylvie Comte, James A. Bonner

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression

    Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hy... mā Rafał Dziadziuszko, Daniel T. Merrick, Samir E. Witta, Adelita D. Mendoza, Barbara Szostakiewicz, Amelia Szymanowska, Witold Rzyman, Katarzyna Dziadziuszko, Jacek Jassem, Paul A. Bunn, Marileila Varella‐Garcia, Fred R. Hirsch

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer

    Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer mā Andrew Wardley, Xavier Pivot, Flavia Morales-Vàsquez, Luis Miguel Zetina, Maria de Fátima Dias Gauí, Douglas Otero Reyes, Jacek Jassem, Claire Barton, Peter Button, Veronica Hersberger, A. Antón Torres

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: